| Literature DB >> 31768473 |
Evan Berger1, Ghassan Ghorayeb1, Jeffery Hogg2.
Abstract
PURPOSE: To report an atypical case of acute posterior multifocal placoid pigment epitheliopathy (APMPPE) with central nervous system (CNS) vasculitis and recurrent strokes. OBSERVATIONS: A 57 year-old female presented with APMPPE after a febrile illness and rash. She developed an acute infarct on magnetic resonance imaging. Computed tomography angiography of the cerebral vasculature was normal. Cerebrospinal fluid (CSF) analysis and an extensive serum lab workup were also unremarkable. She was treated with high-dose corticosteroids and eventually transitioned to methotrexate. A month after being on treatment she developed a second stroke. A cerebral angiogram was obtained and did not show evidence of CNS vasculitis. The methotrexate was eventually stopped and the prednisone was tapered. Approximately 3 months later she developed a third stroke and worsening APMPPE-associated maculopathy in both eyes. She was eventually started on oral cyclophosphamide. CONCLUSIONS & IMPORTANCE: Although rare, CNS vasculitis is a known complication of APMPPE. This case is atypical given the development of multiple recurrent strokes, lack of inflammatory evidence on CSF analysis, and normal imaging of the cerebral vasculature. This report highlights the need for a high level of clinical suspicion for CNS vasculitis with APMPPE despite noncontributory cerebral angiographic imaging and normal CSF analysis.Entities:
Keywords: APMPPE; Acute posterior multifocal placoid pigment epitheliopathy; Cerebral vasculitis; Stroke
Year: 2019 PMID: 31768473 PMCID: PMC6872853 DOI: 10.1016/j.ajoc.2019.100574
Source DB: PubMed Journal: Am J Ophthalmol Case Rep ISSN: 2451-9936
Fig. 1Clinical presentation (A–F) with recurrence 9 months later (G–I). Fundus photographs of the right (A) and left eye (B) at initial presentation. In the right eye there are multiple creamy, yellow-white placoid lesions within the macula. The left eye is not yet affected. Two weeks later the left eye becomes involved (C). Fluorescein angiogram (FA) of the right eye at initial presentation shows blockage in the early phase (D) followed by late staining (E). Spectral domain ocular coherence tomography (SD-OCT) of the right eye at initial presentation (F) demonstrates subretinal fluid and ellipsoid zone disruption. Fundus photograph (G), near-infrared photography (H), and SD-OCT (I) of the left eye 9 months later showing recurrence with small subretinal hemorrhage (G, arrowheads) and new subretinal fluid (I). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Fig. 2Magnetic resonance imaging (MRI) - initial (A-D) and follow up (E-H). A focal, chronic infarct in the right lateral aspect of the upper pons appears hyperintense on both diffusion-weighted imaging (DWI) (A) and apparent diffusion coefficient (ADC) map (B). An acute infarction in the right thalamus is demonstrated by the combination of a hyperintense signal on DWI (C) and marked hypointense signal on ADC (D). Follow up imaging shows interval development of two new infarcts (E-H). A chronic infarct is seen within the genu and anterior limb of the left internal capsule (E–F). It appears hyperintense on both DWI (E) and ADC map (F). A more acute punctate infarct is seen within the left anterior subinsular region (G–H). The combination of hyperintense signal on DWI (G) and hypointense signal on ADC (H) indicates an acute process.
Recurrent strokes in APMPPE-associated CNS vasculitis.
| Case Report | Year Reported | Gender | Age (years) | Number of Strokes | CSF Studies | Neuroimaging |
|---|---|---|---|---|---|---|
| Smith et al. | 1983 | M | 25 | 2 | WBC 100 cells/μL | |
| Weinstein et al. | 1988 | M | 23 | 2 | WBC 19 cells/μL | |
| Comu et al. | 1996 | F | 23 | 2 | WBC 60 cells/μL | |
| O'Halloran et al. | 2001 | M | 16 | 2 | WBC 28 cells/hpf | |
| O'Halloran et al. | 2001 | F | 38 | 4 | IgG index 0.77 | |
| Bugnone et al. | 2006 | F | 20 | 2 | Not performed | |
| Luneau et al. | 2009 | M | 43 | 2 | WBC 253 cells/mm3 | |
| Matamala et al. | 2013 | M | 15 | 2 | WBC 13 cells/mm3 | |
| Tsuboyama et al. | 2018 | M | 64 | 2 | Not performed | |
| Tsuboyama et al. | 2018 | M | 55 | 2 | WBC 21/hpf | |
| Present case | 2019 | F | 57 | 3 | No abnormalities |